Doctorate in Tumor Biology from All India Institute of Medical Science, and post
postdoctoral research in signal transduction alterations in adenocarcinomas at National
Institute of Immunology; Dr. Anu is a seasoned scientific leader with over 20 years
of comprehensive experience in new drug discovery and early preclinical drug development
and scientific operations with special interest in translatory research of photochemical
based products. Dr. Anu was instrumental in discovery and development of first-in-world
clinical candidate Nanoxel™ (a polymeric Nanoparticle based drug delivery system
for Paclitaxel). Anu holds over 14 US Patents and more than 46 in rest of the world
and several more in India. She has published and presented more than 30 research
papers in peer-reviewed journals & scientific meetings.